When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
FOLD - Amicus Therapeutics acquires gene therapy portfolio of ten clinical and pre-clinical stage AAV programs in neurologic lysosomal storage disorders
Amicus Therapeutics Inc.
Amicus Therapeutics (NASDAQ:FOLD) signs a definitive agreement in which it will receive worldwide development and commercial rights for ten gene therapy programs developed at The Center for Gene Therapy at The Research Institute at Nationwide Children’s Hospital and The Ohio State University.
More news on: Amicus Therapeutics, Inc., Healthcare stocks news,